Insights - Magenta reported preliminary data from their Phase 2 in mobilizing Multiple Myeloma patients and it was phenomenal. Concurrently, with the data announcement, Magenta also closed a $86M financing with … Continue Reading
PremiumResearch - The ASCO 2021 meeting is going to be June 4-8. This morning, ASCO 2021 abstract titles were released. May 19th is when selected abstracts (details other than just … Continue Reading
PremiumInsights - Affimed(AFMD) hosted a call after market today to discuss cbNK+AFM13 data presented at AACR. KOL from MD Anderson Dr. Katy Rezvani was also on the call. Below … Continue Reading
PremiumResearch - 9 Meters (NMTR) is developing a novel treatment for short bowel syndrome (“SBS”) by focusing on slowing food transit time through the gastrointestinal (“GI”) tract. … Continue Reading
PremiumResearch - Nine Meters Biopharma (NMTR) NMTR has reported top-line Phase 1b/2a data for Short Bowel Syndrome (“SBS”). The gastrointestinal (“GI”) tract is the tract from the mouth to the … Continue Reading
PremiumResearch - Genocea is using neoantigens to develop a cancer vaccine that can add precision to TIL therapy and improve its efficacy. Iovance has validated TIL therapy. … Continue Reading
PremiumInsights - Essa (EPIX) announced a collaboration with Janssen (Johnson & Johnson’s biotech arm) yesterday morning to combine EPI-7386 with their blockbuster anti-androgen drugs. Janssen will be responsible for … Continue Reading
Premium
